DELÅRSRAPPORT JANUARI-JUNI 2016
July 15, 2016 01:30 ET
|
Lifco AB
Rapportperioden januari - juni
· Nettoomsättningen ökade med 14,3% till 4 424 (3 870) MSEK, organiskt ökade
nettoomsättningen med 6,2%
· EBITA* ökade med 16,9% till 681 (583) MSEK
·...
Delårsrapport januari-juni 2016 Nordax Bank AB
July 15, 2016 01:30 ET
|
Nordax Bank AB
Nordax Bank AB (publ) publicerar idag sin delårsrapport för perioden januari
-juni 2016.
Nordax Bank AB (publ) är ett helägt dotterbolag till Nordax Group AB (publ).
För ytterligare information...
Interim report January-June 2016 Nordax Bank AB (publ)
July 15, 2016 01:30 ET
|
Nordax Bank AB
Nordax Bank AB (publ) today publish the interim report for the period January
-June 2016.
Nordax Bank AB (publ) is a fully owned subsidiary to Nordax Group AB (publ).
For more information, please...
Nordax Group delårsrapport januari-juni 2016
July 15, 2016 01:30 ET
|
Nordax Group AB
JANUARI-JUNI 2016
Siffror jämfört med januari-juni 2015
• Låneportföljen ökade med 14,8% i oförändrade valutor
• Räntenettomarginalen ökade till 9,3% (8,5%)
• Totala rörelseintäkter uppgick till...
INTERIM REPORT JANUARY – JUNE 2016
July 15, 2016 01:30 ET
|
Lifco AB
Reporting period January – June
· Net sales increased by 14.3 per cent to SEK 4,424 (3,870) million.
Organically, net sales grew by 6.2 per cent
· EBITA* increased by 16.9 per cent to SEK 681...
Extension of the acceptance period of XVIVO Perfusion’s public offer on Vivoline Medical has ended
July 15, 2016 01:30 ET
|
Xvivo Perfusion AB
The Offer is not made, and this press release may not, directly nor indirectly,
be distributed in or to, Australia, Hong Kong, Japan, Canada, New Zeeland, South
Africa or the U.S or in any other...
Nordax Group Interim Report January-June 2016
July 15, 2016 01:30 ET
|
Nordax Group AB
JANUARY-JUNE 2016
Numbers compared with January-June 2015
• Loan portfolio increased by 14.8% in constant currencies
• Net interest margin increased to 9.3% (8.5%)
• Total operating income...